Patient Survey Reveals Significant Physical Burden of Psoriatic Disease
Researchers sought to assess patients’ understanding of the systemic nature of psoriatic disease.
Diagnosis & Disease Information
Psoriasis Progression to Inflammatory Arthritis Reduced With Biologics
Researchers evaluated the association between biological therapy and the time to incident inflammatory psoriatic arthritis.
Machine Learning Accurately Predicts Biologic Discontinuation in Psoriasis
Researchers assessed the accuracy of a traditional statistical risk factor-based model versus machine learning in predicting the 5-year probability of biologic discontinuation.
Biologics May Reduce Psoriatic Arthritis Development in Patients With Psoriasis
Researchers assessed whether biologics reduce the incidence of psoriatic arthritis among patients with psoriasis.
Targeted Therapies Do Not Increase Cardiovascular Risk in Psoriasis
Researchers sought to investigate the effect of targeted therapies on cardiovascular risk in psoriasis and psoriatic arthritis.
Psoriatic Arthritis Linked to Comorbidity Burden, Ustekinumab Persistence in Psoriasis
The researchers sought to evaluate whether there was an association between the presence of psoriasis and concomitant psoriatic arthritis and comorbidity burden and treatment outcomes.
Amjevita, a Biosimilar to Humira, Now Available
Amjevita is supplied as a 40 mg/0.8 mL single-dose prefilled SureClick autoinjector, and as 20 mg/0.4 mL and 40 mg/0.8 mL single-dose prefilled syringes.
Systemic Agent Initiation for Psoriasis Is Highest in Spring
Does systemic agent prescribing for psoriasis vary by season or other exacerbating factors?
How Does Physical Exercise Affect Rheumatic Disease Outcomes?
Though patients with rheumatic diseases may think physical activity may exacerbate their pain and fatigue, studies show that exercise can be beneficial to disease activity. How does exercise impact certain rheumatic conditions?
In Psoriatic Arthritis, Screening for Comorbidities Guides Treatment Selection
A GRAPPA working group highlighted the importance of screening for comorbidities to guide treatment selection among patients with psoriatic arthritis.
- Loading...
Loading...
Next post in News
Loading... 
Loading...